REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,750.00
Bid: 1,750.00
Ask: 1,750.50
Change: 16.50 (0.95%)
Spread: 0.50 (0.029%)
Open: 1,736.00
High: 1,751.50
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks gain ahead of central bank announcements

Thu, 04th Oct 2012 08:23

- Investors await BoE and ECB decisions, FOMC minutes- Tate & Lyle jumps after Credit Suisse upgrades- Halfords appoints new CEO after strong Q2European stock markets have opened with moderate gains ahead of what is likely to be a busy day on the economic front, with rate decisions due out from the Bank of England (BoE) and European Central Bank (ECB) later today, as well as the minutes of the latest Federal Reserve meeting.The BoE's Monetary Policy Committee (MPC) is set to reveal whether it has made any alterations to its key interest rate and asset purchase programme (also known as quantitative easing, or QE) at noon.The smart money is on there being no change, with the interest rate staying at 0.5% and the asset purchase (quantitative easing, or QE) pot staying at £375bn. However, some are expecting an increase in QE and a 25 basis point rate cut in November.The ECB is also expected to remain in 'wait-and-see' mode when it reveals its policy decision after midday. Analysts believe that the ECB will wait for Spain to make the next move considering that it already announced its bond purchase plan for ailing countries that request aid. The key interest rate currently stands at 0.75% after it was cut by 25 basis points early in the year. The deposit rate is at 0%. Analyst Craig Erlam from Alpari said: "There's been a lack of volatility in the markets in recent weeks as investors look beyond central banks to the governments for reassurance on the next step in the debt crisis. The uncertainty surrounding Spain has left investors unsure on how to position themselves as we approach near end. Given a lack of details out of the eurozone, there is a hope that the ECB will give us some valuable insight into this."Meanwhile, the Federal Open Market Committee (FOMC) minutes are also on the agenda for later. Analyst Moyeen Islam from Barclays Research said this morning that the minutes should provide more "granularity regarding what the Fed may judge to be a 'sustainable improvement' in the labour market that would underpin any decision to end the current open-ended commitment to asset purchases.FTSE 100: Tate & Lyle gains after broker upgradeSweeteners and food products group Tate & Lyle was the high riser in early trading after Credit Suisse raised its recommendation for the stock from 'neutral' to 'outperform'. The broker said: "There is no easy way to value Tate & Lyle, but it does seem to us to be a better business for all the changes we have seen and that this is not reflected in the share price (which is down 8% year to date versus a staples sector up 18%)."Evraz fell after acquiring an indirect controlling interest in OJSC Raspadskaya, one of Russia's largest producers of coking coal and a supplier to the Russian steel firm.Pharmaceuticals behemoth GlaxoSmithKline gained after saying its joint venture company, Shionogi-ViiV Healthcare, has completed an initial clinical registration package for dolutegravir, its treatment for HIV patients.Supermarket peers Tesco and Sainsbury were among the stocks in the red following their results and trading update yesterday, respectively. Exane BNP Paribas reduced its target price for Tesco this morning from 325p to 300p and reiterated its 'underperform' rating on the shares. FTSE 250: Halfords surges after impressive Q2, new CEO appointmentCar and bike parts retailer Halfords jumped after appointing a new Chief Executive Officer following the abrupt departure of David Wild in the summer, as it revealed that full-year profits would be at the top end of guidance after a strong second quarter.The company expects pre-tax profit to be in the region of £40-42m in the first half on the back of its second quarter performance and an acceleration of operating cost investment. The consensus estimate currently stands at just £35.8m. Fashion chain Ted Baker was in demand after saying that the reaction to its autumn/winter collections has been positive as it unveiled a solid first-half trading performance. FTSE 100 - RisersTate & Lyle (TATE) 691.50p +2.52%Standard Chartered (STAN) 1,421.00p +1.21%Prudential (PRU) 833.00p +1.09%Carnival (CCL) 2,336.00p +0.99%InterContinental Hotels Group (IHG) 1,655.00p +0.98%Barclays (BARC) 222.30p +0.93%International Consolidated Airlines Group SA (CDI) (IAG) 165.20p +0.92%Royal Bank of Scotland Group (RBS) 260.40p +0.89%Diageo (DGE) 1,795.00p +0.84%ITV (ITV) 91.95p +0.82%FTSE 100 - FallersEvraz (EVR) 239.60p -3.11%BHP Billiton (BLT) 1,929.00p -0.72%Tesco (TSCO) 325.75p -0.67%G4S (GFS) 266.50p -0.56%BG Group (BG.) 1,302.00p -0.53%BP (BP.) 436.85p -0.50%CRH (CRH) 1,183.00p -0.50%Johnson Matthey (JMAT) 2,406.00p -0.46%Amec (AMEC) 1,145.00p -0.43%British Land Co (BLND) 521.00p -0.29%FTSE 250 - RisersHalfords Group (HFD) 302.00p +13.53%Ted Baker (TED) 945.00p +3.45%Victrex (VCT) 1,372.00p +3.08%Stobart Group Ltd. (STOB) 115.40p +2.58%Ocado Group (OCDO) 67.70p +2.27%Rentokil Initial (RTO) 84.85p +2.23%Computacenter (CCC) 385.00p +2.18%Paragon Group Of Companies (PAG) 212.30p +2.07%Lonmin (LMI) 548.00p +2.05%FirstGroup (FGP) 197.30p +2.02%FTSE 250 - FallersRank Group (RNK) 146.90p -2.39%Hansteen Holdings (HSTN) 76.30p -2.18%Carpetright (CPR) 630.00p -2.10%IP Group (IPO) 118.60p -1.58%JD Sports Fashion (JD.) 709.00p -1.53%Dechra Pharmaceuticals (DPH) 583.00p -1.10%Bovis Homes Group (BVS) 495.20p -1.06%Kenmare Resources (KMR) 39.75p -1.00%Petra Diamonds Ltd.(DI) (PDL) 115.20p -0.95%Utilico Emerging Markets Ltd (DI) (UEM) 160.12p -0.86%BC
More News
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.